
Cannabis Gummies: Complete India Guide to Vijaya Edibles, Dosage & Effects
Article Summary
If you've been searching for cannabis gummies in India, you're entering one of the most rapidly evolving segments of Ayurvedic and therapeutic wellness. Cannabis gummies â edible confections infused with cannabinoids like THC, CBD, or full-spectrum V...
If you've been searching for cannabis gummies in India, you're entering one of the most rapidly evolving segments of Ayurvedic and therapeutic wellness. Cannabis gummies â edible confections infused with cannabinoids like THC, CBD, or full-spectrum Vijaya extract â are transforming how Indians access and experience this ancient medicinal herb. From traditional Mewa Modak Vati preparations rooted in classical Ayurveda to modern precision-dosed gummy formulations, this guide covers everything: how cannabis gummies work in the body, how to dose them safely, their legal status under India's NDPS Act and AYUSH framework, and which products are available to order legally online in India today.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new supplement or treatment. Cannabis-based products may require a prescription in India under NDPS Act regulations. Book a consultation with our panel doctors for personalized guidance.
What Are Cannabis Gummies?
Cannabis gummies are edible products infused with one or more cannabinoids â the active chemical compounds found in the Cannabis sativa plant (known in India as Vijaya or Vijaya patta). Unlike smoking or vaping, gummies deliver cannabinoids through the digestive system, resulting in a slower onset, longer duration, and often more body-centred effect profile.
Globally, cannabis gummies are available in multiple formulations: THC-dominant (psychoactive), CBD-dominant (non-intoxicating), or balanced full-spectrum (containing both THC and CBD along with terpenes, minor cannabinoids and other plant compounds that synergise in what researchers call the "entourage effect"). In India, the regulatory landscape under the NDPS Act 1985 and AYUSH guidelines determines which of these formulations can be produced, prescribed, and sold legally â more on that below.
The Indian Ayurvedic tradition has long embraced cannabis edibles. Classical preparations like Vijaya modak, Mewa Modak Vati, and Trailokya Vijaya Vati are the direct Ayurvedic predecessors of what the modern world calls cannabis gummies. These preparations were documented in the Charaka Samhita and Sushruta Samhita for uses ranging from pain relief to sleep and digestive support.
How Cannabis Gummies Work: The Science of Edible Cannabinoids
Understanding how cannabis gummies work begins with the endocannabinoid system (ECS) â a vast network of receptors, enzymes, and endogenous cannabinoids present throughout the human body. The ECS regulates critical functions including pain perception, sleep, appetite, mood, memory, and immune response. CB1 receptors are concentrated in the brain and central nervous system; CB2 receptors dominate in immune tissues and peripheral organs.
When you consume cannabis gummies, the cannabinoids (THC, CBD, or a blend) travel through your gastrointestinal tract. In the liver, THC is converted into 11-hydroxy-THC â a metabolite that is significantly more potent than inhaled THC and crosses the blood-brain barrier more effectively. This explains why edible cannabis gummies produce a stronger, longer-lasting effect compared to smoking or vaping the same dose.
Onset time for cannabis gummies typically ranges from 45 minutes to 2 hours, depending on individual metabolism, body weight, and whether you've eaten recently. Effects can last 4â8 hours, sometimes longer. This delayed onset is one of the most common causes of accidental overdose â new users often consume a second gummy before the first has taken effect. Always wait at least 2 hours before re-dosing.
CBD gummies work differently. CBD does not directly bind to CB1 or CB2 receptors but modulates the ECS indirectly â inhibiting the enzyme that breaks down anandamide (the body's natural "bliss molecule"), interacting with serotonin receptors (5-HT1A), and modulating TRPV1 pain receptors. The clinical result is anxiolytic, anti-inflammatory, and analgesic effects without psychoactive intoxication.
Types of Cannabis Gummies Available in India
The market for cannabis gummies in India is more varied than many consumers realise. Here are the primary categories:
CBD Gummies (Hemp-Derived)
Containing less than 0.3% THC, CBD gummies are derived from industrial hemp and are the most widely available cannabis edibles in India. They are non-intoxicating, do not produce a "high," and are primarily used for anxiety relief, sleep support, and inflammation management. FSSAI and AYUSH regulations permit hemp-derived CBD products under specific licensing conditions.
Vijaya Extract Gummies (Full-Spectrum)
Vijaya extract gummies are the Indian Ayurvedic equivalent of full-spectrum cannabis edibles. They contain the complete phytochemical profile of the Cannabis sativa leaf â THC, CBD, CBN, terpenes, and flavonoids â at ratios standardised under AYUSH manufacturing protocols. These require a doctor's prescription under current Indian law and are produced by AYUSH-licensed manufacturers. Their effects are more comprehensive and often faster than pure CBD preparations.
Ayurvedic Vati and Modak Preparations
Traditional Mewa Modak Vati and Trailokya Vijaya Vati are classical Ayurvedic edible preparations â compressed tablets or confections incorporating standardised Vijaya extract alongside complementary herbs. These represent India's indigenous cannabis gummy tradition, predating the modern gummy format by millennia. They are prescribed by Ayurvedic practitioners for pain, sleep disorders, anxiety, and neurological conditions.
Balanced THC:CBD Formulations
Some AYUSH-licensed products offer specific THC:CBD ratios â commonly 1:4 or 2:1 â tailored to different therapeutic targets. Higher CBD ratios reduce psychoactive intensity and are generally preferred for daytime use; higher THC ratios are more appropriate for severe chronic pain or insomnia under medical supervision.
Cannabis Gummies Dosage Guide: Starting Safe in India
Cannabis gummies dosage is highly individual and depends on body weight, tolerance, metabolism, the specific cannabinoid profile, and your therapeutic goal. The universal starting rule is: start low, go slow. Here is a general framework for Indian consumers approaching cannabis edibles for the first time:
| Experience Level | CBD Gummies Dose | Vijaya/Full-Spectrum Dose | Wait Before Re-dosing | Best Use Case |
|---|---|---|---|---|
| First-timer (Beginner) | 5â10 mg CBD | 2.5â5 mg Vijaya extract | 2 hours minimum | Anxiety, mild sleep issues |
| Occasional User | 10â25 mg CBD | 5â10 mg Vijaya extract | 90 minutes | Stress relief, moderate pain |
| Regular User | 25â50 mg CBD | 10â20 mg Vijaya extract | 60 minutes | Chronic pain, sleep disorders |
| Medical (Supervised) | 50â150 mg CBD | 20â50 mg+ (doctor only) | As prescribed | Neuropathic pain, cancer-related symptoms |
Important: Ayurvedic Vijaya preparations (Mewa Modak Vati, Trailokya Vijaya Vati) have their own standardised dosing listed on the product â always follow AYUSH-prescribed guidelines. For personalised dosing guidance, consult one of our panel doctors who specialise in cannabis medicine and can tailor a protocol to your specific health goals.
Effects of Cannabis Gummies: What to Expect
The effects of cannabis gummies vary significantly based on the cannabinoid profile, dose, and individual biochemistry. Understanding what to expect â and how to distinguish a therapeutic response from unwanted side effects â is essential for safe use.
CBD-Dominant Cannabis Gummies
CBD gummies typically produce a subtle shift in mental state: reduced anxiety, improved sense of calm, and occasionally mild drowsiness at higher doses. Physical effects include reduced inflammation, relaxed muscles, and diminished pain signals. Most users report that the experience feels natural and non-intoxicating â like the absence of stress rather than the presence of a drug.
Vijaya/Full-Spectrum Cannabis Edibles
Full-spectrum Vijaya extract products produce a more complex experience. At therapeutic doses under medical supervision, users often report significant pain relief, improved sleep quality, reduced anxiety, and muscle relaxation. At higher doses or in users with low tolerance, THC-containing preparations may produce psychoactive effects including altered perception, increased appetite, and impaired short-term memory. These effects are dose-dependent and temporary.
Common Side Effects
Even at therapeutic doses, cannabis gummies can cause dry mouth, increased heart rate, red eyes, and dizziness â particularly in first-time users. Rare but serious adverse effects at high doses include paranoia, anxiety exacerbation, and nausea. Always begin with the lowest effective dose and increase gradually under medical guidance.
Are Cannabis Gummies Legal in India? The NDPS Act and AYUSH Framework
This is the most critical question for Indian consumers: are cannabis gummies legal in India? The answer is nuanced and depends entirely on the product's cannabinoid composition and how it's manufactured and sold.
The Narcotic Drugs and Psychotropic Substances (NDPS) Act 1985 prohibits cannabis resin (charas/hashish) and the flowering tops of the cannabis plant (classified as "marijuana" under the Act). However, the Act explicitly excludes leaves and seeds of the cannabis plant from the definition of narcotics â this exclusion is the legal foundation for hemp-derived CBD and Ayurvedic Vijaya preparations in India.
CBD gummies derived from hemp (less than 0.3% THC) are legal when manufactured by AYUSH-licensed facilities, classified appropriately as Ayurvedic Proprietary Medicine or food supplements under FSSAI guidelines, and sold through authorised retail channels. No prescription is required for compliant hemp-derived CBD products.
Vijaya extract (full-spectrum cannabis leaf extract) preparations â including Mewa Modak Vati and similar classical formulations â fall under Schedule E-1 of the Drugs and Cosmetics Act and require an AYUSH licence to manufacture and a valid prescription to obtain. Products sold on THC Store India comply fully with these requirements. Always ensure any cannabis gummy or edible you purchase is clearly labelled with its cannabinoid content, manufacturing licence, and dosing instructions.
As of 2026, several state governments have also issued specific guidelines on Vijaya extract products. Consult our doctor consultation service to understand what is appropriate for your state and health condition before purchasing.
Cannabis Gummies vs. Other Cannabis Delivery Methods: A Complete Comparison
Why choose cannabis gummies or edibles over other delivery formats? Here's a data-driven comparison to help Indian consumers decide:
| Feature | Cannabis Gummies/Edibles | CBD Oil/Tincture | Vaporizer | Topicals/Balms |
|---|---|---|---|---|
| Onset Time | 45 min â 2 hrs | 15â45 min (sublingual) | 2â10 min | 20â60 min (local) |
| Duration | 4â8 hours | 2â4 hours | 1â3 hours | 2â6 hours (local) |
| Bioavailability | 4â20% (variable) | 20â35% (sublingual) | 30â50% | Minimal systemic |
| Ease of Dosing | Very easy (pre-dosed) | Moderate (drop counting) | Requires device | Topical, not systemic |
| Discretion | High (looks like candy) | Moderate | Low (visible vapour) | High |
| Taste | Pleasant (fruity) | Earthy/plant-like | Herbal | Topical only |
| Best For | Long-lasting relief, sleep | Rapid anxiety/pain relief | Fastest acute relief | Localised joint/muscle pain |
Top Cannabis Edibles and Vijaya Extract Products Available in India
The following cannabis gummies and edible products are legally available through THC Store India's cannabis edibles collection. All products are manufactured by AYUSH-licensed brands with standardised cannabinoid content and quality testing.
Sanan Mewa Modak Vati â Classical Ayurvedic Cannabis Edible
Sanan's Mewa Modak Vati is a 10,500 mg standardised cannabis edible based on the classical Ayurvedic Mewa Modak formulation. Each tablet contains a precise dose of Vijaya extract combined with complementary herbs that traditionally enhance bioavailability and therapeutic effect. Indicated for chronic pain, anxiety, and sleep disorders, this is one of India's most authentic cannabis edible preparations available online. Available in THC Store's Vijaya extract collection.
Sanan Relief Kam Modak Vati â Targeted Pain Edible
The Sanan Relief Kam Modak Vati (175g) is designed specifically for pain management, combining standardised Vijaya extract with Ayurvedic analgesic herbs including Shallaki, Rasna, and Ashwagandha. This preparation bridges classical Indian pain management with modern cannabis medicine. Particularly effective for arthritis, neuropathic pain, and musculoskeletal conditions when taken as part of a doctor-supervised protocol. Book a consultation to determine appropriate dosing for your condition.
Oral Onco Care by ZenOnco â Medicinal Cannabis Oral Preparation
ZenOnco's Oral Onco Care (1000mg) is a medically formulated oral cannabis preparation designed to support oncology patients. With standardised cannabinoid content and pharmaceutical-grade quality testing, it represents the intersection of modern evidence-based medicine and Indian cannabis therapeutics. Available with a prescription through THC Store's doctor consultation service.
Calmosis Green Mantra â Full-Spectrum Vijaya Extract
The Calmosis Green Mantra Full-Spectrum Vijaya Extract delivers the complete phytochemical profile of Vijaya leaf in a convenient oral form. Full-spectrum preparations harness the entourage effect â the synergistic interaction of cannabinoids, terpenes, and flavonoids that produces superior therapeutic outcomes compared to isolated compounds. A strong choice for consumers seeking comprehensive wellness support from cannabis edibles.
CannaBlithe DoDay/DoNight Combo â AM/PM Cannabis Protocol
The CannaBlithe Balanced AM/PM Combo provides two complementary cannabis formulations for day and night use â an energising, CBD-forward daytime formula and a THC-balanced sleep-support night formula. This is one of the most thoughtfully designed cannabis edible systems available in India, allowing users to maintain consistent endocannabinoid support throughout the day without compromising daytime function. Explore the full cannabis edibles range on THC Store.
Cannabis Gummies for Specific Health Conditions
Clinical and traditional evidence supports the use of cannabis gummies and edibles for a growing range of health conditions. Here is what the current research shows, with Indian regulatory context:
Chronic Pain
This is the most robust area of cannabis therapeutics. Full-spectrum Vijaya extract edibles â with both THC and CBD â show consistent efficacy for neuropathic pain, arthritic pain, and cancer-related pain. The 2024 MedCan 3 RCT (BMC Trials, PMC11140951) â one of the most rigorous oral cannabinoid trials â specifically studied oral THC:CBD (1:20 ratio) for cancer symptom burden, showing significant relief. Edibles are particularly suited to chronic pain due to their long duration of action.
Anxiety and Stress
A 2025 systematic meta-analysis of 29 studies (1,100+ participants) found CBD-dominant cannabis formulations produced consistent, clinically meaningful reductions in anxiety symptoms. CBD's interaction with the 5-HT1A serotonin receptor is thought to be a key mechanism. Cannabis gummies with high CBD-to-THC ratios (1:20 or CBD isolate) are appropriate for daytime anxiety management without impairment. Read our complete guide to cannabis for anxiety.
Sleep Disorders
Cannabis edibles are one of the most commonly reported reasons for use among Indian patients. THC-containing edibles shorten sleep latency and increase slow-wave sleep, while CBD at higher doses (50â160 mg) also shows sleep-promoting effects via cortisol modulation. However, long-term nightly use of THC can suppress REM sleep and lead to REM rebound on discontinuation â a known and manageable phenomenon. Edibles are ideal for sleep due to their long duration covering the full sleep cycle. Learn more about cannabis for sleep in India.
Inflammation and Autoimmune Conditions
Both CBD and THC have demonstrated anti-inflammatory activity through CB2 receptor modulation and NF-ÎșB pathway suppression. Full-spectrum cannabis edibles are increasingly being explored in clinical settings for conditions like Crohn's disease, rheumatoid arthritis, and multiple sclerosis. In India, AYUSH-licensed preparations like Vijaya extract are available for these indications under physician supervision.
Oncology Support
Cannabis edibles play a growing role in palliative cancer care in India â particularly for chemotherapy-related nausea, appetite loss, pain, and sleep disturbances. ZenOnco's medical-grade oral preparations and CannaBlithe's formulations are specifically designed for this population with appropriate dosing protocols. Always consult an oncologist and cannabis-specialist physician before use.
How to Buy Cannabis Gummies in India Legally
Purchasing cannabis gummies legally in India involves three simple steps:
- Consult a qualified doctor. For Vijaya extract preparations, an AYUSH or allopathic prescription is required. THC Store's panel of doctors offer online consultations and can issue legal prescriptions for appropriate cannabis edible formulations. For pure CBD hemp products, no prescription is needed.
- Choose a compliant product. Only buy from AYUSH-licensed manufacturers. All products on THC Store India are sourced from verified, licensed brands. Look for batch testing certificates (COAs), cannabinoid content labelling, and AYUSH manufacturing licence numbers on the packaging.
- Order online with confidence. THC Store delivers cannabis edibles and Vijaya extract preparations across India with discreet, legal packaging. Orders are processed within 24 hours with pan-India courier delivery. Browse the full cannabis edibles catalogue.
Clinical Research on Cannabis Gummies: What the Science Says
The evidence base for cannabis gummies and oral cannabinoid preparations has expanded dramatically over the past five years. Here are the key findings relevant to Indian consumers:
Bioavailability variability: A 2024 Cannabis Clinical Outcomes Research Conference analysis (PMC11498913) confirmed significant inter-individual variation in cannabinoid pharmacokinetics. This explains why identical doses produce different effects in different people â and underscores the importance of personalised dosing under medical supervision.
Anxiety and sleep: A landmark 2025 meta-analysis of 29 CBD RCTs (1,100+ participants) found CBD-dominant formulations significantly reduced anxiety and improved sleep quality across multiple study populations, with a favourable safety profile. THC-dominant formulations showed higher rates of adverse effects but also greater efficacy for severe pain.
Cancer symptom relief: The MedCan 3 RCT (BMC Trials, 2024) demonstrated that oral THC:CBD preparations at a 1:20 ratio significantly reduced cancer-related symptom burden in a multicentre, double-blind, placebo-controlled trial â one of the strongest clinical confirmations of edible cannabis effectiveness in an oncology context.
Safety signal: A 2024 population study noted that approximately 29% of long-term medical cannabis users showed indicators of cannabis use disorder (CUD). This highlights the importance of medically supervised use, appropriate dosing, and regular clinical reassessment for anyone using cannabis edibles regularly. Our doctor consultation service includes ongoing monitoring support.
Research on specifically Indian populations and on Ayurvedic Vijaya preparations is growing â AYUSH-funded clinical studies on Mewa Modak Vati and Trailokya Vijaya Vati are ongoing at several major Ayurvedic institutions, with preliminary results confirming efficacy comparable to classical literature references.
Cannabis Gummies and Vijaya Extract: An Ayurvedic Perspective
For Indian consumers, cannabis edibles are not a foreign import â they are a homecoming. Vijaya (the victorious one) has been described in the Charaka Samhita as one of the most potent of medicinal plants, particularly for conditions involving vata imbalance (the Ayurvedic dosha associated with the nervous system, pain, and anxiety).
Classical Ayurvedic formulations like Mewa Modak Vati were traditionally used during seasonal transitions, for neurological disorders, and for conditions requiring deep tonification of the nervous system. The "edible" delivery format was chosen by Ayurvedic physicians for a specific reason: oral preparations produce the slowest, most sustained release, making them ideal for chronic conditions requiring consistent therapeutic blood levels rather than acute symptom relief.
Modern pharmacology now validates this traditional wisdom. The first-pass hepatic metabolism that converts THC into 11-hydroxy-THC produces longer-duration, often deeper therapeutic effects â exactly what chronic pain, sleep disorders, and anxiety conditions require. India's Ayurvedic cannabis heritage gives Indian patients a deep cultural and traditional framework for understanding and using cannabis edibles safely and effectively.
Cannabis Gummies Dosage Protocol: Practical Guide for Indian Users
Here is a practical cannabis gummies dosage protocol for Indian consumers based on common therapeutic goals:
For Anxiety/Stress Management: Start with 10 mg CBD (from a hemp-derived CBD gummy or equivalent Vijaya extract dose) once daily in the evening. After 7â10 days with no adverse effects, increase to twice daily (morning and evening). Most users find a stable maintenance dose of 20â50 mg CBD/day over 4â6 weeks of consistent use. For prescription Vijaya extract formulations, follow the prescribing doctor's protocol.
For Sleep Support: Take your cannabis gummy or Vijaya vati 60â90 minutes before intended sleep time to account for the edible's delayed onset. CBD doses of 25â100 mg have shown sleep-supporting effects in clinical studies. Full-spectrum Vijaya extract preparations (under prescription) may be more effective for severe insomnia.
For Chronic Pain: Cannabis edibles for pain management typically require consistent dosing rather than as-needed use. A morning and evening protocol â mirroring the CannaBlithe DoDay/DoNight approach â maintains stable cannabinoid blood levels that are more effective for chronic pain than peak-and-trough single doses. Consult our specialist doctors for a personalised pain protocol.
For First-Time Users (General Wellness): Start with a low-dose CBD gummy (5â10 mg) once daily for the first week, observing effects on mood, sleep, and energy. Gradually titrate upward by 5 mg per week until you find your minimum effective dose. Many users are surprised to find their optimal dose is lower than expected.
Frequently Asked Questions About Cannabis Gummies in India
Are cannabis gummies the same as CBD gummies in India?
Not exactly. CBD gummies are a specific type of cannabis gummy containing CBD (cannabidiol) as the primary active compound, derived from hemp with less than 0.3% THC. Cannabis gummies is a broader term that includes full-spectrum Vijaya extract preparations, THC:CBD balanced products, and Ayurvedic Vati formulations. In India, all legally available edible cannabis products are either hemp-derived CBD formulations or AYUSH-licensed Vijaya extract preparations. Read our complete cannabis edibles India guide for more detail.
How long do cannabis gummies take to work in India?
Cannabis gummies â whether CBD gummies, Vijaya extract preparations, or Ayurvedic Vati formulations â typically take 45 minutes to 2 hours to produce noticeable effects. Onset depends on individual metabolism, body weight, and food intake. Taking cannabis gummies on an empty stomach may accelerate onset; taking them with a high-fat meal can increase cannabinoid absorption (bioavailability). Always wait at least 2 hours before taking an additional dose.
Can I take cannabis gummies with other medications in India?
Cannabis, including CBD, can interact with multiple medications by inhibiting cytochrome P450 liver enzymes (CYP3A4, CYP2D6) that metabolise many common drugs. This can increase or decrease blood levels of other medications. Never use cannabis edibles alongside blood thinners, anti-epileptics, antidepressants, or immunosuppressants without first consulting your doctor. Book a consultation to review potential drug interactions for your specific medication list.
Are cannabis gummies addictive in India?
CBD gummies are not considered addictive. Pure CBD has no known dependence potential and is not scheduled as a controlled substance in India. Full-spectrum Vijaya extract preparations containing significant THC do carry a risk of psychological dependence with long-term heavy use â studies suggest approximately 9% of users who try cannabis develop dependence (the figure rises to 17% for those who start in adolescence). Medically supervised use with appropriate dosing significantly mitigates this risk. Our doctors can help you use cannabis therapeutically with appropriate safeguards.
Where can I buy legal cannabis gummies online in India?
Legal cannabis gummies and Vijaya extract edibles are available from AYUSH-licensed brands on THC Store India. THC Store is India's leading Vijaya extract platform, offering products from verified manufacturers with complete quality documentation, discreet pan-India delivery, and access to specialist doctor consultations for prescription products. Browse the Vijaya extract collection or book a consultation to start your therapeutic cannabis journey today.
What is the difference between cannabis gummies and Mewa Modak Vati?
Cannabis gummies are the modern, typically gelatin or pectin-based confections infused with cannabinoid extract. Mewa Modak Vati is the classical Ayurvedic Indian equivalent â a compressed tablet or modak (traditional sweet preparation) incorporating standardised Vijaya extract with complementary Ayurvedic herbs. Both deliver cannabinoids orally and share the same delayed-onset, long-duration pharmacokinetic profile. The Vati formulation offers the added benefit of synergistic Ayurvedic herbs that can enhance therapeutic effects and reduce side effects according to classical formulation principles.
How should I store cannabis gummies or Vijaya edibles in India's climate?
Cannabis edibles should be stored in a cool, dark, airtight container away from heat and humidity â particularly important in India's tropical climate. Excessive heat degrades cannabinoids, especially THC. Store at room temperature below 25°C if possible; refrigeration is acceptable for longer-term storage. Keep out of reach of children and pets. Check product-specific storage instructions on the packaging.
Buying Guide: What to Look for in Cannabis Gummies in India
With a growing market for cannabis gummies in India, knowing how to evaluate product quality is essential. Here is what to look for:
- AYUSH Manufacturing Licence: All legitimate cannabis edible manufacturers in India must have an AYUSH licence. This is the non-negotiable quality threshold â never buy from brands that cannot produce this documentation.
- Certificate of Analysis (COA): A third-party lab test report confirming the cannabinoid content, absence of heavy metals, pesticides, and microbial contamination. Look for COAs from NABL-accredited Indian labs or ISO-certified international labs.
- Clear Cannabinoid Labelling: The product should clearly state CBD content per serving (in mg), THC content (should be below 0.3% for hemp-derived CBD products), and total cannabinoid profile for full-spectrum preparations.
- Ingredient Transparency: Legitimate cannabis gummies list all ingredients including sweeteners, pectin or gelatin source, flavourings, and any added herbs or adaptogens.
- Manufacturer Reputation: Established brands like Sanan, CannaBlithe, ZenOnco, and others available on THC Store India have verifiable track records and customer reviews.
Read our complete guide to buying legal cannabis gummies in India for a step-by-step walkthrough of the verification process.
The Future of Cannabis Gummies in India
The trajectory for cannabis gummies and edibles in India is strongly upward. AYUSH policy has been progressively expanding the scope of legally permissible Vijaya extract products. Several states â including Uttarakhand, Himachal Pradesh, and Madhya Pradesh â have established cannabis cultivation and processing frameworks that are producing the raw material for India's growing cannabis wellness industry.
Globally, the research base for cannabis edibles continues to expand, with Phase 3 clinical trials underway for oral cannabinoid preparations in cancer, neuropathic pain, epilepsy, and anxiety disorders. As Indian clinical research catches up â particularly the AYUSH-funded studies on Vijaya preparations â we expect increasing mainstream acceptance and broader access to cannabis gummies and edibles as legitimate therapeutic tools.
For Indian consumers, the opportunity is now: access to high-quality, legally compliant cannabis edibles through platforms like THC Store India, combined with online access to specialist cannabis doctors, means that therapeutic cannabis gummies are more accessible to Indian patients than at any previous time in history.
Whether you're exploring cannabis gummies for anxiety, pain, sleep, or overall wellness, the key is to start with good information, consult a qualified physician, and choose AYUSH-compliant products from verified manufacturers. Book your consultation today and take the first step toward personalised cannabis therapy.
Sources and References
- PMC11498913 â Proceedings of the 2024 Cannabis Clinical Outcomes Research Conference. PubMed Central, 2024. Key finding: Significant pharmacokinetic variability in edible cannabinoid formulations; THC dose-response non-linear for psychoactive effects.
- PMC11140951 â MedCan 3 RCT Protocol: Multicentre, double-blind, placebo-controlled trial of THC:CBD (1:20) for cancer symptom burden. BMC Trials, 2024. Key finding: Oral cannabinoid preparation significantly reduced cancer-related symptom burden versus placebo in a rigorous Phase 3 design.
- Meta-analysis of 29 CBD RCTs (2025) â Pooled analysis of 1,100+ participants in randomised controlled trials of CBD-dominant formulations. Published December 2025. Key finding: CBD significantly reduced anxiety symptoms and improved sleep quality across multiple study populations; evidence for other indications remains limited.
- University of Colorado Cannabinoid Cohort Study (2024) â ~300 participant comparison of CBD-dominant vs. THC-dominant oral products. Key finding: CBD-dominant formulations outperformed THC-dominant products for anxiety reduction without psychoactive adverse effects.
- NDPS Act 1985, Government of India â Section 2(iii) and Second Schedule. Legal basis for the exclusion of cannabis leaves and seeds from narcotic classification; foundation of India's hemp and Vijaya extract legal framework.
Share this article
Written by
THC Store Editorial
Published 1 months ago



